β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol

Bibliographic Details
Main Authors:	Bhatt, Surya P, Connett, John E, Voelker, Helen, Lindberg, Sarah M, Westfall, Elizabeth, Wells, J Michael, Lazarus, Stephen C, Criner, Gerard J, Dransfield, Mark T
Format:	Online
Language:	English
Published:	BMJ Publishing Group 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908863/

Similar Items

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
by: Sean Duffy, et al.
Published: (2017-06-01)

The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model
by: Sadatsafavi, Mohsen, et al.
Published: (2016)

Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease
by: Geiger-Brown, Jeanne, et al.
Published: (2015)

Differential DNA methylation marks and gene comethylation of COPD in African-Americans with COPD exacerbations
by: Busch, Robert, et al.
Published: (2016)

Determinants of successful completion of pulmonary rehabilitation in COPD
by: Brown, Angel T, et al.
Published: (2016)

Determinants of arterial stiffness in COPD
by: Bhatt, Surya P, et al.
Published: (2014)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
by: Seung Won Ra, et al.
Published: (2017-05-01)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
by: O'Reilly, Philip J, et al.
Published: (2013)

β blockers for heart failure
by: Hoes, Arno W
Published: (2016)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
by: Lipworth, Brian, et al.
Published: (2016)

Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease
by: Albert, Richard K, et al.
Published: (2012)

Exacerbations of COPD
by: Pavord, Ian D, et al.
Published: (2016)

Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD
by: Wells, J Michael, et al.
Published: (2013)

Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study
by: Wetherbee, Erin E, et al.
Published: (2015)

Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort
by: Busch, Robert, et al.
Published: (2016)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
by: Erickson, Catherine E., et al.
Published: (2013)

Lung microbiology and exacerbations in COPD
by: Beasley, Victoria, et al.
Published: (2012)

Exacerbation frequency and course of COPD
by: Halpin, David MG, et al.
Published: (2012)

β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
by: Andell, Pontus, et al.
Published: (2015)

Beta-Blockers Reduced the Risk of Mortality and Exacerbation in Patients with COPD: A Meta-Analysis of Observational Studies
by: Du, Qingxia, et al.
Published: (2014)

COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry
by: Leung, Janice M., et al.
Published: (2016)

β-blockers: a novel class of antitumor agents
by: Ji, Yi, et al.
Published: (2012)

Should β-blockers be used in septic shock?
by: Lira, Alena, et al.
Published: (2014)

Systematic review of use of β-blockers in sepsis
by: Chacko, Cyril Jacob, et al.
Published: (2015)

Airway wall thickness is increased in COPD patients with bronchodilator responsiveness
by: Kim, Victor, et al.
Published: (2014)

Life-Space mobility and clinical outcomes in COPD
by: Iyer AS, et al.
Published: (2018-09-01)

Relevance of human metapneumovirus in exacerbations of COPD
by: Rohde, G, et al.
Published: (2005)

Virus-induced exacerbations in asthma and COPD
by: Kurai, Daisuke, et al.
Published: (2013)

Rhinovirus-Induced Exacerbations of Asthma and COPD
by: Hershenson, Marc B.
Published: (2013)

Optimizing bronchodilation in the prevention of COPD exacerbations
by: Marc Miravitlles, et al.
Published: (2017-06-01)

COPD exacerbations by disease severity in England
by: Merinopoulou, Evie, et al.
Published: (2016)

Stress Cardiomyopathy in the Setting of COPD Exacerbation
by: Landefeld, Kevin, et al.
Published: (2015)

Acute exacerbation of COPD: is it the “stroke of the lungs”?
by: Hillas, Georgios, et al.
Published: (2016)

Chronic Bronchitis and Current Smoking Are Associated with More Goblet Cells in Moderate to Severe COPD and Smokers without Airflow Obstruction
by: Kim, Victor, et al.
Published: (2015)

Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
by: Short, Philip M, et al.
Published: (2011)

Effect of Perioperative β-Blockers on Pulmonary Complications among Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Resection Surgery
by: Kamath, A., et al.
Published: (2015)

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease
by: Kubota, Yoshiaki, et al.
Published: (2015)

Glycation exacerbates the neuronal toxicity of β-amyloid
by: Li, X-H, et al.
Published: (2013)

β-Blockers in sepsis: protocol for a systematic review and meta-analysis of randomised control trials
by: Duan, Erick H, et al.
Published: (2016)

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial
by: Beeh, Kai M, et al.
Published: (2013)